Clinical Trials Logo
  1. Home
  2. Alcohol Withdrawal Syndrome
  3. NCT02146716

Assessment of Energetic Resonance by Cutaneous Stimulation on Withdrawal Alcohol Symptoms. — RESC  

Alcohol Withdrawal Syndrome Clinical Trial

Official title:
Assessment of Energetic Resonance by Cutaneous Stimulation on Withdrawal Alcohol Symptoms.

Clinical Trial Summary

The purpose of RESC study is to assess the efficacy of Energetic Resonance by Cutaneous Stimulation on alcohol withdrawal symptoms measured by CUSHMAN score and in a second time to measure the benzodiazepine amount prescribed during the withdrawal time.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02146716
Study type Interventional
Source Hospices Civils de Lyon
Contact
Status Completed
Phase N/A
Start date May 2014
Completion date February 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT03033823 - MAGnesium Adjunction in Alcohol Withdrawal Syndrome: a Multicenter Assessment (MAGMA) Phase 3
Completed NCT01637415 - The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS) N/A
Completed NCT04973202 - Portrayal of Hospital Alcohol Detoxification in France
Terminated NCT02052440 - Preventing Alcohol Withdrawal Syndrome With Oral Baclofen Phase 3
Completed NCT01652326 - Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome N/A
Recruiting NCT03235531 - Assessment of Valproate on Ethanol Withdrawal Phase 4
Completed NCT00146471 - Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome Phase 3
Completed NCT02090504 - Comparative Study of Gamma-hydroxy Butyrate Versus Oxazepam in the Treatment of Alcohol Withdrawal Syndrome Phase 4
Completed NCT03012815 - Gabapentin for Alcohol Withdrawal Syndrome Phase 4
Completed NCT05438641 - Treatment of Alcohol Withdrawal Syndrome With Alpha-2 Agonists and/or Anticonvulsants
Completed NCT00249366 - Treatment of Alcohol Withdrawal in Hospital Patients Phase 4
Withdrawn NCT03788889 - Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine Phase 4